News Focus
News Focus
icon url

Horseb4CarT

08/04/22 2:32 AM

#501008 RE: HyGro #501007

Wrong again!
icon url

VikingInvest

08/04/22 3:57 AM

#501012 RE: HyGro #501007

Lack of due diligence will always bring about some interesting narratives. You should invest or not invest based on your own views. Obviously this is your view. Good luck.
icon url

FeMike

08/04/22 6:27 AM

#501019 RE: HyGro #501007

How about Press Release 10/5/20 announcing unblinding. then the 3/21 10K that announces a "New" protocol, endpoints, comparator and SAP,



NWBO wasn’t unblinded and the 10/5 press release neither said nor implied that. Quit with the blatantly false claims. Data lock occurred 10/5, unblinding did not happen until well after March of ‘21
icon url

Roman516

08/04/22 9:13 AM

#501052 RE: HyGro #501007

The press release from 10/5/20 was light years ago with respect to all the recent and more positive attributes associated to NWBO. Case in point, the current accomplishments regarding the data results from the 5/10/22 presentation.
"Presentation About Phase 3 Trial of DCVax®-L for Glioblastoma To Be Made At New York Academy Of Sciences." However, lies and deceptive individuals and media cause NWBO's SP to tank, and then months later redact their works to CYA, but could be still liable for their initial lies and deceptive media comments?

The fact is that DCVax-L works but there are paid individuals who will continue to make up anything to contradict the facts. They will use outdated risk factors based on old information; they will twist their stories no matter what. Again, the facts are clear, and NWBO will persevere and be able to help many cancer patients who are the ones that will benefit from DCVax-L.